One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants
Paola Pellanda, Yuki Otani, Christopher D. Payne, Edward V. Loftus et al.
Journal
Advances in Therapy
Topics
Rheumatoid Arthritis Research and Therapies
article
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants
Paola Pellanda, Yuki Otani, Christopher D. Payne, Edward V. Loftus, Geert D’Haens, Shomron Ben‐Horin, Abhishek Upadhya K, Galen H. Shi, Xin Zhang, Kristin Todd
article en
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 43(1)
Institutions
Eli Lilly (United States) (US), Sheba Medical Center (IL), Mayo Clinic in Arizona (US), Amsterdam University Medical Centers (NL)